The forecasted import values of Theophylline and Aminophylline to Japan exhibit a consistent declining trend from 2024 to 2028, starting at 608.64 thousand USD in 2024 and reducing to 485.02 thousand USD by 2028. This reflects a year-on-year decrease, with an average annual compound growth rate (CAGR) of approximately -5.5% over the five years. In 2023, before the forecasted period, imports stood at a higher comparative level, suggesting a continuing reduction in import volumes going forward.

Future trends to watch for:

Potential shifts in domestic production capacities affecting import needs.
Regulatory changes impacting pharmaceutical imports.
Market demand variations linked to healthcare trends and treatment advancements.